logo of Canadian Cancer Society, Cancer Trials Canada and OncoQuébec

About Cancer Trials Canada

Cancer Trials Canada

The Canadian Cancer Society (CCS) and the Quebec - Clinical Research Organization in Cancer (Q-CROC) have joined forces to establish a unified, patient-first, bilingual program to improve access to clinical trials for all Canadians.

This innovative program aims to connect cancer patients with research teams by leveraging an innovative, patient-friendly technology solution that will make it easier to find, understand and access clinical trials.

CCS is a recognized leader in Canada for credible and accessible cancer information, and Q-CROC has pioneered a comprehensive 360-degree platform that has been expanded nationwide. Our collaborative vision, in partnership with other organizations, seeks to create an agile and sustainable solution that will advance and promote innovation in cancer care.

This program was made possible in part through collaboration and financial support from the Canadian Partnership Against Cancer (CPAC).

CCS and Q-CROC

Canadian Cancer Society Logo
The Canadian Cancer Society works tirelessly to save and improve lives. We fund the brightest minds in cancer research. We provide a compassionate support system for all those affected by cancer, from coast to coast and for all types of cancer. As the voice for Canadians who care about cancer, we work with governments to establish health policies to prevent cancer and better support those living with the disease. No other organization does all that we do to improve lives today and to change the future of cancer forever.
QCROC Logo
The Quebec - Clinical Research Organization in Cancer is a not-for-profit organization founded 16 years ago by two visionary oncologists. We improve recruitment strategies, making clinical research more accessible to people affected by cancer and healthcare professionals. Since launching OncoQuébec in 2019, we have been operating this innovative platform to connect patients with clinical trials and support the advancement of cancer research.